Cargando…
Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants
BACKGROUND: Very preterm infants are at risk of developing retinopathy of prematurity (ROP). Recombinant human erythropoietin (rhEPO) is routinely used to prevent anemia in preterm infants; however, the effect of rhEPO on ROP development is still controversial. The purpose of this study was to evalu...
Autores principales: | Sun, Huiqing, Song, Juan, Kang, Wenqing, Wang, Yong, Sun, Xiantao, Zhou, Chongchen, Xiong, Hong, Xu, Falin, Li, Mingchao, Zhang, Xiaoli, Yu, Zengyuan, Peng, Xirui, Li, Bingbing, Xu, Yiran, Xing, Shan, Wang, Xiaoyang, Zhu, Changlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574422/ https://www.ncbi.nlm.nih.gov/pubmed/33076939 http://dx.doi.org/10.1186/s12967-020-02562-y |
Ejemplares similares
-
Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016) -
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage
por: Song, Juan, et al.
Publicado: (2021) -
Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial
por: Wang, Yong, et al.
Publicado: (2020) -
The effect of leucocytosis on retinopathy of prematurity
por: Sun, Zhihong, et al.
Publicado: (2023) -
The Impact of Different Degrees of Intraventricular Hemorrhage on Mortality and Neurological Outcomes in Very Preterm Infants: A Prospective Cohort Study
por: Wang, Yong, et al.
Publicado: (2022)